1Lang O, Yogev Y, Xenakis E, et al. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.Am J Obes. & Gyne 2005;192:134- 139. 被引量：1
2Tuffnell DJ, West J, Walkinshaw SA. Treatment for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst Rev 2003;(3) :CD003395. 被引量：1
3Sivan E, Boden C. Free fatty acids, insulin resistance, and pregnance. Curr Diab Rep 2003;3(4):319- 322. 被引量：1
4Siddiqui F, James D. Fetal monitoring in type 1 diabetic pregnancies. Early Hum Dev 2003;72(1):1 - 13. 被引量：1
5Langer O. Oral hypoglycemic agents in pregnancy: their time has com.J Matem Fetal Neonatal Med 2002;12(6):376-383. 被引量：1
7American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003. 被引量：1
8Preece R, Jovanovic L. New and future diabetes therapies: are they safe during pregnancy? J Matern Fetal Neonatal Med 2002 , 12 (6) :365 -375. 被引量：1
9Reece EA, Homko C, Miodovink M, Langer O. A consensus report of the diabete in pregnancy study group of North America Conference, Little Rock, Arkansas, May, 2002, J Matern Fetal Neonatal Med 2002 ; 12(6) :362 - 364. 被引量：1
10Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the US preventive Service Task Force. Obstet Gynecol 2003 ; 101(2) :380 - 392. 被引量：1
10International Association of Diabetes and Pregnancy Study Groupsconsensus panel. International Association of Diabetes and Preg-nancy Study Groups recommendations on the diagnosis and classi-fication of hyperglycemia in pregnancy[ J]. Diabetes care,2010,33 :676-682. 被引量：1
